cefaclor anhydrous has been researched along with Infections, Klebsiella in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (50.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Dobashi, M; Ikeda, M; Ishii, J; Koguchi, D; Murakami, Y | 1 |
Stille, W | 1 |
Ritzerfeld, W | 1 |
Dark, D | 1 |
Cazzola, M; Franco, C; Gioia, V; Legnani, D; Mancini, V; Polverino, M; Sevieri, G | 1 |
Lionell, C; Magni, L | 1 |
Niki, Y; Soejima, R; Tasaka, Y; Umeki, S; Watanabe, M | 1 |
3 trial(s) available for cefaclor anhydrous and Infections, Klebsiella
Article | Year |
---|---|
[Results of treatment with cefaclor, a new oral cephalosporin].
Topics: Cefaclor; Cephalexin; Drug Evaluation; Humans; Klebsiella Infections; Otitis Media; Penicillins; Respiratory Tract Infections; Skin Diseases, Infectious; Staphylococcal Infections; Urinary Tract Infections | 1979 |
Multicenter evaluation of azithromycin and cefaclor in acute lower respiratory tract infections.
Topics: Azithromycin; Bronchitis; Cefaclor; Erythromycin; Haemophilus Infections; Humans; Klebsiella Infections; Moraxella catarrhalis; Neisseriaceae Infections; Pneumonia; Prospective Studies; Sputum; Staphylococcal Infections; Streptococcal Infections | 1991 |
Cefaclor in the treatment of infective exacerbations of chronic bronchitis in cigarette smokers.
Topics: Adult; Aged; Aged, 80 and over; Bronchitis; Cefaclor; Chronic Disease; Drug Administration Schedule; Female; Haemophilus Infections; Humans; Klebsiella Infections; Male; Middle Aged; Neisseriaceae Infections; Respiratory Tract Infections; Smoking; Sputum; Staphylococcal Infections | 1991 |
5 other study(ies) available for cefaclor anhydrous and Infections, Klebsiella
Article | Year |
---|---|
Cefaclor as a first-line treatment for acute uncomplicated cystitis: a retrospective single-center study.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Cefaclor; Cefazolin; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Fosfomycin; Humans; Klebsiella Infections; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Proteus Infections; Retrospective Studies; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult | 2020 |
The prognostic value of the antibiogram.
Topics: Amniotic Fluid; Ampicillin; Animals; Anti-Bacterial Agents; Bile; Cefaclor; Cephalexin; Escherichia coli Infections; Fosfomycin; Gentamicins; Humans; In Vitro Techniques; Kanamycin; Klebsiella Infections; Microbial Sensitivity Tests; Urine | 1983 |
[Influence of cefaclor on experimental pyelonephritis (author's transl)].
Topics: Animals; Cefaclor; Cephalexin; Cephradine; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Pyelonephritis; Rats | 1979 |
In vivo efficacy of cefcanel daloxate in comparison with cefaclor.
Topics: Absorption; Animals; Bacterial Infections; Cefaclor; Cephalosporins; Disease Models, Animal; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Prodrugs; Staphylococcal Infections | 1990 |
Therapeutic effect of fleroxacin against experimental pneumonia in mice.
Topics: Animals; Anti-Infective Agents; Cefaclor; Ciprofloxacin; Fleroxacin; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Pipemidic Acid | 1988 |